ARTICLE | Company News
Bayer, Inverness sales and marketing update
December 5, 2005 8:00 AM UTC
BAYG's Bayer Diagnostics division received an option to commercialize worldwide IMA's Urotensin marker for congestive heart failure (CHF) on Bayer's automated immunoassay systems. The companies also p...